Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - bordetella bronchiseptica - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.0 u - immunotherapy

Stati Uniti - Ingliż - NLM (National Library of Medicine)

glaxosmithkline biologicals sa - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (unii: 8c367iy4ey) (bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) - unii:8c367iy4ey), bordetella pertussis pertactin antigen (formaldehyde inactivated) (unii: i05o535nv6) (bordetella pertussis pertactin antigen (formaldehyde inactivated) - unii:i05o535nv6), bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (unii: qsn5xo8zsu) (bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) - unii:qsn5xo8zsu), poliovirus type 1 antigen (formaldehyde inactivated) (unii: 0lvy784c09) (poliovirus type 1 antigen (formaldehyde inactivated) - unii:0lvy784c09), poliovirus type 2 antigen (formaldehyde inactivated) (unii: 23je9kdf4r) (poliovirus type 2 antigen (formaldehyde inactivated) - unii:23je9kdf4r), poliovirus type 3 antigen (formaldehyde inactivated) (unii: 459rom8m9m) (poliovirus type 3 antigen (formaldehyde inactivated) - unii:459rom8m9m) - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) 25 [iu] in 0.5 ml - a single dose of kinrix is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (dtap) vaccine series and the fourth dose in the inactivated poliovirus vaccine (ipv) series in children aged 4 through 6 years (prior to the seventh birthday) whose previous dtap vaccine doses have been with infanrix (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) and/or pediarix [diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis b (recombinant) and inactivated poliovirus vaccine] for the first 3 doses and infanrix for the fourth dose. severe allergic reaction (e.g., anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, pertussis- or poliovirus-containing vaccine, or to any component of kinrix, including neomycin and polymyxin b, is a contraindication to administration of kinrix [see description (11)] . because of the uncertainty as to which component of the vaccine might be responsible, no further vaccination with any of these components should be given. alternatively, such individuals may be referred to an allergist for evaluation if immunization with any of these components is considered. encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) within 7 days of administration of a previous dose of a pertussis-containing vaccine that is not attributable to another identifiable cause is a contraindication to administration of any pertussis-containing vaccine, including kinrix. progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, or progressive encephalopathy, is a contraindication to administration of any pertussis-containing vaccine, including kinrix. pertussis vaccine should not be administered to individuals with such conditions until a treatment regimen has been established and the condition has stabilized. safety and effectiveness of kinrix in children younger than 4 years and children aged 7 to 16 years have not been evaluated. kinrix is not approved for use in persons in these age groups.

Malta - Ingliż - Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection in pre-filled syringe - pertactin 2.5 µg pertussis toxoid 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu diphtheria toxoid filamentous haemagglutinin (fha) 8 µg tetanus toxoid - vaccines

Singapor - Ingliż - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - microbiology - recommended for use in slide agglutination tests for the identification of bordetella pertussis and bordetella parapertussis.

Singapor - Ingliż - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - microbiology - recommended for use in the direct fluorescent antibody technique for the identification of bordetella pertussis and bordetella parapertussis.

Singapor - Ingliż - HSA (Health Sciences Authority)

premier diagnostics pte. ltd. - immunology - purified dna of bordetella parapertussis to be used to control in vitro diagnosis techniques based in nucleic acids amplification.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

trp company - spongia officinalis skeleton, roasted (unii: 1pip394iid) (spongia officinalis skeleton, roasted - unii:1pip394iid), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), protortonia cacti (unii: lzb7tfx1lt) (protortonia cacti - unii:lzb7tfx1lt), drosera rotundifolia (unii: qr44n9xpjq) (drosera rotundifolia - unii:qr44n9xpjq), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), calcium sulfide (unii: 1mbw07j51q) (calcium sulfide - unii:1mbw07j51q), human sputum, bordetella pertussis infected (unii: u364v64hun) (human sputum, bordetella pertussis infected - unii:u364v64hun) - according to homeopathic indications these ingredients provide temporary relief of symptoms of bronchial cough such as: • coughing • mucous build-up • chest tightness and • chest soreness after diagnosis by a physician.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

boiron - human sputum, bordetella pertussis infected (unii: u364v64hun) (human sputum, bordetella pertussis infected - unii:u364v64hun) - rx only* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

sanofi pasteur europe - filamentous haemagglutinin, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate), hepatitis b surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (mahoney strain) produced on vero cells, poliovirus (inactivated) type 2 (mef-1 strain) produced on vero cells, poliovirus (inactivated) type 3 (saukett strain) produced on vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, diphtheria toxoid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines - hexyon (dtap-ipv-hb-hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib).the use of this vaccine should be in accordance with official recommendations.

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi pasteur europe s.a. - bordetella pertussis filamentous hemagglutinin (fha) 5 µg/dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; bordetella pertussis pertactin 3 µg/dose; bordetella pertussis toxoid (pt) 2,5 µg/dose; bordetella pertussis purified fimbrial agglutinogens 2 and 3 (fim) 5 µg/dose; diphtheria toxoid (dt) 2 ; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; tetanus toxoid 20 - suspension for injection - 0,5 ml - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus